New treatments are needed to reduce the risk of progression of coronavirus disease 2019 (Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback